Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.
Kota V Ramana, Satish K Srivastava
Index: Cytokine 36(3-4) , 115-22, (2006)
Full Text: HTML
Abstract
Aldose reductase (AR; AKR1B1) a member of aldo-keto reductase super family, that we had shown earlier mediates cytotoxic signals induced by high glucose, cytokines and growth factors, also mediates the inflammatory signals induced by Gram-negative bacterial endotoxin, lipopolysaccharide (LPS). Inhibition of AR by three distinct AR inhibitors sorbinil, tolrestat or zopolrestat suppressed the LPS-induced production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, IFN-gamma, and chemokine MCP-1 in murine peritoneal macrophages. Inhibition of AR also prevented the production of nitric oxide, and prostaglandin E2 and expression of iNOS and Cox-2 proteins. The LPS-induced DNA binding activity of NF-kappaB and AP1 were significantly inhibited by AR inhibitors, and this effect was mediated through the inhibition of phosphorylation of IkappaB-alpha, IKK alpha/beta and PKC. These results suggest the therapeutic use of AR inhibitors as anti-inflammatory drugs.
Related Compounds
Related Articles:
2012-01-01
[PLoS ONE 7(4) , e31399, (2012)]
Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.
2014-05-01
[Invest. Ophthalmol. Vis. Sci. 55(5) , 2853-61, (2014)]
2015-06-05
[Chem. Biol. Interact. 234 , 254-60, (2015)]
Prevention of posterior capsular opacification through aldose reductase inhibition.
2009-02-01
[Invest. Ophthalmol. Vis. Sci. 50(2) , 752-9, (2009)]
Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.
2008-04-04
[J. Biol. Chem. 283(14) , 9101-12, (2008)]